Department of Chemical Pharmacology, Faculty of Pharmaceutical
Sciences, University of Tokushima, Shomachi, Tokushima 770, Japan
 |
Introduction |
Some
local anesthetics have been reported to inhibit agonist-induced
desensitization in various tissues. For example, tetracaine inhibits
desensitization of the beta adrenoceptor system (Mallorga et al., 1980
), muscarinic receptor system (Hishinuma and
Uchida, 1991
) and histamine H1 receptor system
(Hishinuma and Uchida, 1987
; Horio et al., 1997
). Similarly,
procaine inhibits desensitization of the muscarinic and histamine
H1 receptor system (Magaribuchi et
al., 1973
; Hishinuma and Uchida, 1987
; Horio et al.,
1997
), and some related compounds like quinacrine and chloroquine, with a similar chemical structure to amine local anesthetics, also inhibit
desensitization of various systems (Mallorga et al., 1980
; Higuchi et al., 1982
; Siegel et al., 1984
).
These drugs have several common actions on the receptor-mediated
cellular processes in approximately the same concentration range.
First, all of them are phospholipase A2
inhibitors. Second, tetracaine and procaine have inhibitory effects on
voltage-dependent Ca++ channels in smooth muscle
cells (Ishii and Shimo, 1984
; Spedding and Berg, 1985
; Ahn and Karaki,
1988
). Third, some of them interact with muscarinic and histamine
H1 receptors (Burgermeister et al., 1978
; Aguilar et al., 1980
; Fairhurst et al.,
1980
; Taylor et al., 1980
; Horio et al., 1997
).
At present, however, it is not clear whether these local anesthetics
inhibit various types of desensitization through a common mechanism or
their respective mechanisms, although their inhibitory actions have
been, in some cases, attributed to the inhibition of phospholipase
A2 (Mallorga et al., 1980
) or to
receptor blockade (Horio et al., 1997
).
In the present study, we examined the effects of these local
anesthetics on acetylcholine-induced desensitization of guinea pig
ileal smooth muscle to clarify the mechanism with which these drugs
inhibit desensitization of muscarinic receptor system. Especially, we
focused on their interaction with the receptors because our previous
study showed that these drugs inhibited histamine-induced desensitization mainly through their blocking action on histamine H1 receptors (Horio et al., 1997
).
 |
Methods |
Measurement of contractile responses.
Guinea pigs of either
sex, weighing 250 to 500 g, were killed by a blow on the head and
cutting of the throat (this study was approved by the Institutional
Animal Care and Use Committee of the University of Tokushima). The
ileum was removed, and strips of longitudinal muscle were obtained
according to the method of Rang (1964)
. The strips were suspended in
Tyrode's solution at 31°C and bubbled with air under a resting
tension of ~0.5 g. The Tyrode's solution had the following
composition (in mM): NaCl 136.9, KCl 2.7, CaCl2
1.8, MgCl2 1.05, NaH2PO4 0.42, NaHCO3 11.9 and glucose 5.6. Isotonic
contractions were recorded with a lever on a smoked drum.
The effects of quinacrine, chloroquine, tetracaine and procaine on the
contractile responses to acetylcholine were examined as follows. First,
a cumulative dose-response curve to acetylcholine was examined. Then,
the muscle strip was treated with one of the drugs for 10 min, and the
dose-response curve was re-examined in the continued presence of the
drug. Essentially the same results were obtained when the pretreatment
was for 30 min. These drugs shifted the dose-response curve to the
right at low concentrations, and the dissociation constant
(KB) was determined from the parallel shift of the curve according to Arunlakshana and Schild (1959)
. The
dose-ratio method of Paton and Rang (1965)
was used to test whether
these drugs were acting in a competitive manner.
Ca++-induced contractions in
K+-depolarized muscle were examined as follows.
First, the muscle strip was fully relaxed in
K+-depolarizing Tyrode's solution (composition
in mM of KCl 40, NaCl 99.6, MgCl2 1.05, NaH2PO4 0.42, NaHCO3 11.9, glucose 5.6), and then a cumulative
dose-response curve to CaCl2
(10
4 to 10
2
M) was examined. The muscle strip was then treated with one of the
above drugs for 10 min in K+-depolarizing
Tyrode's solution, and the dose-response curve to CaCl2 was reexamined in the continued presence of
the drug.
Measurement of desensitization.
Cumulative dose-response
curves to acetylcholine were measured on a longitudinal muscle strip at
intervals of ~1 hr. The muscle strip was then treated with a
desensitizing agent (10
4 M acetylcholine)
for 30 min. After washing of the muscle with Tyrode's solution for 10 min, the dose-response curve for acetylcholine was reexamined. The
curve shifted almost in parallel to the right after this desensitizing
treatment. The dose-ratio for shifted dose-response curves was
determined to assess the extent of desensitization (Paton, 1961
; Horio
et al., 1990b
). Here, the dose-ratio is the ratio of the
concentration of acetylcholine required to elicite 50% of maximal
response after the desensitizing treatment to the concentration needed
to elicite the same response in the control experiment.
To investigate the effects of local anesthetics on desensitization, the
muscle strip was pretreated with each drug for 10 min and then treated
with the desensitizing agent (10
4 M
acetylcholine) in the continued presence of the drug for 30 min and
washed for 10 min, and the dose-response curve was examined.
The effect of atropine on desensitization was examined as follows.
Here, the pretreatment with atropine affected responses to
acetylcholine profoundly even after the 10-min washout. Therefore, we
examined responses to histamine after the desensitizing treatment (10
4 M acetylcholine and atropine) because
responses to histamine were not affected by the pretreatment with
atropine. Our previous report (Horio et al., 1990b
) showed
that the desensitizing treatment with acetylcholine induced similar
desensitized responses both to acetylcholine and histamine. First,
cumulative dose-response curves to histamine were measured. Then, the
muscle strip was pretreated with atropine for 30 min and treated with
the desensitizing agent (10
4 M
acetylcholine) in the continued presence of atropine for 30 min and
washed for 10 min, and the dose-response curve to histamine was
reexamined.
When the concentration of acetylcholine used for the desensitizing
treatment was varied between 10
7 M and
10
4 M, desensitization was reduced at low
concentrations of acetylcholine compared with the control
(10
4 M acetylcholine). The concentration
of acetylcholine that induced 50% desensitization of the control was
determined from the dose-response (desensitization) curves for
acetylcholine.
In our attempt to check the effects of phospholipase
A2 inhibitors (manoalide and
p-bromophenacyl bromide) on desensitization, the muscle
strip was exposed to the inhibitor drug before (for 30 min) and during
the desensitizing treatment (10
4 M
acetylcholine, 30 min). The control treatment with
10
6 M manoalide or 5 × 10
6 M p-bromophenacyl bromide
for 60 min reduced the tissue responsiveness to acetylcholine slightly,
shifting the dose-response curve to the right. Therefore, the
dose-ratio for desensitization was determined against this shifted
control dose-response curve.
Measurements of binding of [3H]NMS and
[3H]nitrendipine.
For experiments on
[3H]NMS binding, strips of guinea pig ileal
longitudinal muscle were cut into small pieces with scissors and
homogenized in 10 volumes of 50 mM sodium-potassium phosphate buffer
(pH 7.4) with a Polytron homogenizer (Brinkmann Instruments, Westbury,
NY) (setting 6) for three periods of 15 sec at 1-min intervals. The
homogenate was centrifuged at 50,000 × g for 30 min,
and the pellet was resuspended in 5 mM phosphate buffer. Digitonin
(1%) was added to the suspension, and the mixture was stirred for 60 min at 4°C and then centrifuged at 90,000 × g for 60 min. The supernatant was used for binding assay immediately. Incubations in 20 mM Tris·HCl (pH 7.4) contained 500 pM
[3H]NMS, the drugs (quinacrine, chloroquine,
tetracaine and procaine) and the supernatant membrane fraction (0.08 mg
protein) in a total volume of 0.5 ml. Equilibration was for 30 min at
25°C. Incubations were then cooled to 0°C, and a 0.2-ml sample was
applied in duplicate to a column of Sephadex G-50 (preequilibrated with
20 mM Tris·HCl, pH 7.4) and then eluted with 1.1 ml buffer (Haga and
Haga, 1983
). The whole elute was collected in a vial, and the
radioactivity was measured by liquid scintillation spectrophotometry in
a toluene-Triton X-100 base scintillation cocktail. The level of
nonspecific binding was defined as that insensitive to inhibition by 1 µM atropine. It represented <1% of the total binding.
For the measurement of [3H]nitrendipine
binding, membrane preparations were obtained according to the method of
Bolger et al. (1983)
using 50 mM Tris·HCl buffer (pH 7.0).
Incubations in 50 mM Tris·HCl (pH 7.4) contained 300 pM
[3H]nitrendipine, local anesthetics and the
membrane fraction (0.05 mg protein) in a total volume of 1 ml.
Equilibration was for 30 min at 25°C. The incubation was stopped by
dilution with 4 ml of ice-cold Tris buffer, followed by filtration
through Whatman GF/B filters, and the filters were washed twice with 5 ml of ice-cold Tris buffer. The filters were counted by liquid
scintillation spectrophotometry in a toluene-based scintillation
cocktail. The level of nonspecific binding was defined as that
insensitive to inhibition by 10
7 M
nifedipine and was <30% of the total binding. Protein was determined by the method of Lowry et al. (1951)
with bovine serum
albumin as a standard.
Inhibition curves were fitted to the equation:
where B is specific [3H]ligand binding,
Bmax is maximum binding of the
[3H]ligand, I is the concentration of the
inhibitor drug, IC50 is the concentration of the
inhibitor drug inducing half-maximal inhibition of
[3H]ligand binding and n is the Hill
coefficient. The best-fit values of n were obtained by a
nonlinear least-squares curve-fitting procedure; the program was
implemented on a PC-9800 (NEC, Tokyo, Japan) microcomputer system using
the SIMPLEX method (Nelder and Need, 1965
) as previously described
(Horio et al., 1990a
). The dissociation constants
(Ki) were calculated from
IC50 values according to the equation of Cheng
and Prusoff (1973)
.
Calculation of receptor occupancy.
Receptor occupancy in the
presence of the inhibitor drug was calculated by use of a one-site
model with the equation:
where Y is the percentage of receptors occupied by agonist, A is
the concentration of agonist, KA is its
dissociation constant, B is the concentration of the inhibitor drug and
KB is its dissociation constant. In the
calculation, we used KA = 1.0 × 10
6 M (Yamamura and Snyder, 1974
). The
values of KB were obtained from functional
studies as described in the section Measurement of contractile
responses.
Statistics.
Statistical evaluation of significant
differences was performed with Student's t test.
Differences with P values of < .05 were considered statistically
significant.
Drugs.
[3H]NMS (80 Ci/mmol) and
[3H]nitrendipine (74 Ci/mmol) were obtained
from New England Nuclear Research Products (Boston, MA). Quinacrine
dihydrochloride, chloroquine diphosphate, nifedipine and
p-bromophenacyl bromide were purchased from Sigma Chemical (St. Louis, MO). Acetylcholine chloride and procaine hydrochloride were
from Daiichi Pharmaceutical (Tokyo, Japan). Tetracaine hydrochloride was from Kyorin Pharmaceutical (Tokyo, Japan). Atropine sulfate, manoalide and digitonin were from Wako Pure Chemicals (Tokyo, Japan).
 |
Results |
Effect of local anesthetics on desensitization.
Local
anesthetics and related compounds, quinacrine, chloroquine,
tetracaine and procaine inhibited acetylcholine-induced desensitization
in guinea pig ileal longitudinal muscle (fig. 1). Here the extent of desensitization
was assessed by dose-ratios as described previously (Paton, 1961
; Horio
et al., 1990b
). The order of potency was quinacrine > chloroquine > tetracaine > procaine. Values of
pIC50, which denotes negative logarithm of
IC50 for desensitization, are shown in table
1.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 1.
Inhibition by four drugs, quinacrine ( ),
chloroquine ( ), tetracaine ( ) and procaine ( ), of
desensitization in guinea pig ileal longitudinal muscle.
Desensitization was induced by pretreatment with
10 M acetylcholine for 30 min. Dose-ratios
on the ordinate scale were determined as described in Methods to
express the extent of desensitization. Control desensitization was
measured in the absence of any drug and is represented by a dotted line
(dose-ratio = 45.0 ± 1.0). Desensitization in the presence
of the drugs was measured by treating the tissue with the drugs for 10 min before the desensitizing treatment with acetylcholine in the
continued presence of the drugs. Each point is the mean of three
experiments, and S.E.M. values are indicated by vertical bars.
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 1
An index of inhibitory potency of local anesthetics on desensitization
and muscarinic receptors in guinea pig ileal longitudinal muscle
Values of pIC50 for desensitization were obtained from the
results shown in figure 1. The IC50 of procaine could not be
determined because this drug did not inhibit desensitization over 50%
in this experiment. Hill coefficients were obtained by a nonlinear
least-squares regression. Dissociation constants
(pKi) were calculated from concentrations giving
50% inhibition of the binding. Dissociation constants
(pKB) were calculated from the parallel shift of the
dose-response curves for acetylcholine obtained in the presence of
5 × 10 6 M quinacrine, 10 5 M chloroquine,
3 × 10 5 M tetracaine or 10 4 M procaine after
preexposure for 30 min, under which condition maximal response was not
suppressed (>95%). Values are mean ± S.E.M. (n = 3-5).
|
|
Effect of phospholipase A2 inhibitors on
desensitization.
At the concentration of
IC50 for desensitization (4.79 × 10
6 M), quinacrine was fully effective as
a phospholipase A2 inhibitor (e.g., Nishimura et al., 1995
). Thus,
to determine whether the effect of local anesthetics on desensitization
was due to their inhibition of phospholipase
A2 activity, the effect of two specific inhibitors of phospholipase A2, manoalide and
p-bromophenacyl bromide on desensitization was examined.
Both drugs had no significant effect on desensitization (fig.
2).

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 2.
Effects of manoalide and
p-bromophenacyl bromide on desensitization in guinea pig
ileal longitudinal muscle. Desensitization was induced by pretreatment
with 10 M acetylcholine for 30 min, in the
absence (control) or presence of 10 M
manoalide (Mano) or 5 × 10 M
p-bromophenacyl bromide (p-BPB). Dose-ratios were
determined as described in Methods to express the extent of
desensitization. Vertical bars indicate mean ± S.E.M.
(n = 3). Both manoalide and
p-bromophenacyl bromide were without significant effect
on desensitization (P > .05).
|
|
Interaction of local anesthetics with Ca++
channels.
These local anesthetics inhibited
Ca++-induced contractions in
K+-depolarized muscle (fig.
3), indicating that these drugs
interacted with Ca++ channels. Values of
pIC50 for Ca++-induced
contractions are shown in table 2. Local
anesthetics also inhibited [3H]nitrendipine
binding to membrane preparations from guinea pig ileal longitudinal
muscle. The Hill coefficients and pIC50 values are summarized in table 2. The values of Hill coefficient were far
apart from unity and thus we did not further analyze these data. The
rank order of the pIC50 values for both
Ca++-induced contractions and
[3H]nitrendipine binding was quinacrine > chloroquine = tetracaine
procaine and was not in agreement
with the potency order of inhibiting desensitization.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 3.
Inhibition by quinacrine ( ), chloroquine ( ),
tetracaine ( ) and procaine ( ) of Ca++-induced
contraction in K+-depolarized guinea pig ileal longitudinal
muscle. The contractile response obtained at 3 mM CaCl2 was
used as a control. The response examined in the presence of each
inhibitor drug was expressed as a percentage of the control response.
Each point is the mean of four experiments, and S.E.M. values are
indicated by vertical bars.
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 2
An index of inhibitory potency of local anesthetics on Ca++
channels in guinea pig ileal longitudinal muscle
Values of pIC50 for Ca++-induced contractions were
obtained from the results shown in figure 3. Values of pIC50
for [3H]nitrendipine binding (0.3 nM) were obtained from the
curves of inhibition of the binding, and Hill coefficients were
obtained by a nonlinear least-squares regression. Procaine did not
inhibit [3H]nitrendipine binding at 10 2 M. Values
are mean ± S.E.M. (n = 4).
|
|
Interaction of local anesthetics with muscarinic receptors.
Local anesthetics inhibited the binding of
[3H]NMS to solubilized membranes from guinea
pig ileal longitudinal muscle (fig. 4).
The values of the Hill coefficient obtained from the inhibition curves
are shown in table 1. These values were all close to unity, indicating
that these drugs bound to a single site on the receptors. The
dissociation constants (pKi) are shown in
table 1. In this study, we used solubilized receptors instead of
membrane preparations to eliminate the indirect effects of the local
anesthetics through their action on membrane lipids (Seeman, 1972
).
Essentially the same results were obtained by the binding experiments
using membrane preparations (data not shown).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 4.
Inhibition by quinacrine ( ), chloroquine ( ),
tetracaine ( ) and procaine ( ) of [3H]NMS binding to
solubilized membranes prepared from guinea pig ileal longitudinal
muscle. Measurement of the inhibition of the binding of 0.5 nM
[3H]NMS was performed in 20 mM Tris·HCl, pH 7.4. Each
point is the mean of three or four experiments, each performed in
duplicate, and S.E.M. values are indicated by vertical bars.
|
|
Next, to obtain functional affinities
(KB), we examined the effect of local
anesthetics on the dose-response curves for acetylcholine (fig.
5). Quinacrine, chloroquine and
tetracaine shifted the dose-response curve to the right at their low
concentrations (up to 5 × 10
6 M,
10
5 M and 3 × 10
5 M, respectively) but suppressed the
maximum responses at higher concentrations. Procaine (at
10
4 M) did not suppress the maximum
response. The dissociation constants (pKB)
calculated from the initial parallel shift of the curves are shown in
table 1. The pKB values for quinacrine and
chloroquine were not in agreement with the corresponding
pKi values, whereas both the values for
tetracaine and procaine were in good agreement.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 5.
Effects of four drugs, quinacrine (A), chloroquine
(B), tetracaine (C) and procaine (D), on the dose-response curves for
acetylcholine in guinea pig ileal longitudinal muscle, showing control
dose-response curves ( ) and dose-response curves in the presence of
each drug at 3 µM ( ), 10 µM ( ), 30 µM ( ) and 100 µM
( ). Each point is the mean of five experiments, and S.E.M. values
are indicated by vertical bars.
|
|
Therefore, to test further for competitive interaction, we used the
combined dose-ratio method of Paton and Rang (1965)
. If two antagonists
(e.g., atropine and quinacrine), giving
dose-ratios DR1 and DR2,
are competitive with one another, then DR1+2 = DR1 + DR2
1. Here,
DR1+2 represents the dose ratio obtained when
both antagonists are present simultaneously. If the two antagonists are
not competitive with one another, then DR1+2 = DR1DR2. The results are
summarized in table 3. The data showed
that tetracaine and procaine interacted as competitive antagonists at
muscarinic receptors. Chloroquine, which gave values between the
expected values for competition and noncompetition, could be
competitive in part. Quinacrine was not competitive with atropine.
Probably this drug bound to a separate site on the receptors and
inhibited atropine binding to the receptor site.
View this table:
[in this window]
[in a new window]
|
TABLE 3
Dose-ratio test for competitive antagonism of local anesthetics at
muscarinic receptors
Drugs used were 5 × 10 6 M quinacrine, 10 5 M
chloroquine, 3 × 10 5 M tetracaine, 10 4 M
procaine and 10 8 M atropine. The guinea pig ileal
longitudinal muscle strips were pretreated with each drug or a
combination of the drugs for 30 min, and the dose-response curves for
acetylcholine were examined in the presence of the drugs. Dose-ratios
were determined from the parallel shift of the curves. Values are
mean ± S.E.M. (n = 3-5).
|
|
Blockade of muscarinic receptors by local anesthetics.
The
rank order of pKi and
pKB values agreed well with the order of
pIC50 values for desensitization, suggesting that
blockade of the receptors by the local anesthetics was responsible for the inhibition of desensitization. To clarify this point, we calculated the receptor occupancy by agonist in the presence of these inhibitor drugs. For simplicity, we used a one-binding-site model as described in
Methods, although muscarinic receptors of guinea pig ileal muscle have
been shown to be best fitted by a two-binding-site model (Eglen
et al., 1992
). Here, we must note that quinacrine probably
interacted at an allosteric site. The Schild plot for such negative
allosteric ligand is shown to be curvilinear, and the inhibiting effect
of the ligand reaches a plateau at high concentrations (Stockton
et al.,1983
; Ehlert, 1988
). Therefore, when we calculated
receptor occupancy by using the above equation, we might overestimate
the blocking action of quinacrine. The results are summarized in table
4. Receptor occupancy was calculated for
the conditions when the desensitizing treatment (coexistence of agonist
and inhibitor) induced 50% desensitization. For comparison, receptor
occupancy was also calculated for the following two conditions in which
desensitizing treatment was performed: (1) at a low concentration of
acetylcholine (0.93 ± 0.21 µM, n = 5) in the
absence of any inhibitor, or (2) in the presence of atropine (28.0 ± 3.2 nM, n = 4); both treatments gave 50%
desensitization. In the latter experiment, we examined
acetylcholine-induced desensitization of histamine response (see
Methods). Quinacrine, chloroquine and tetracaine had little blocking
effect on muscarinic receptors. Procaine effectively inhibited agonist
binding, to ~50%. The treatment at a low concentration of
acetylcholine (0.93 µM) or in the presence of atropine (28.0 nM) also
inhibited it to a similar extent.
View this table:
[in this window]
[in a new window]
|
TABLE 4
Receptor occupancy by agonist under the various desensitizing
conditions at muscarinic receptors
Receptor occupancy was calculated by use of a one-site model.
Desensitization induced by 10 4 M acetylcholine was used as
control. Receptor occupancy was calculated for the conditions that
induced 50% desensitization, which was obtained either by adding
inhibitor drug (local anesthetic or atropine at a concentration of
IC50 for desensitization) or by reducing the concentration of
desensitizing agent (9.3 × 10 7 M acetylcholine).
|
|
 |
Discussion |
Agonist-induced desensitization, the loss of sensitivity
subsequent to agonist treatment, has long been observed in a wide variety of cellular systems and is generally considered to be due to
events at the signaling pathway. In the present study, we focused on
acetylcholine-induced desensitization and the effect of local
anesthetics on this type of desensitization, especially on the
signaling pathway, although there remained the possibility that local
anesthetics acted through other mechanism such as membrane-stabilizing actions or hydrophobic interactions. Here, we determined which of the
main actions of local anesthetics (i.e., blockade of
receptors, inhibition of phospholipase A2 or
interaction with Ca++ channels) was responsible
for the inhibition of acetylcholine-induced desensitization in guinea
pig ileal smooth muscle.
The potency order of these drugs as a phospholipase
A2 inhibitor is quinacrine > chloroquine > tetracaine > procaine, according to the
literature (Kunze et al., 1976
; Higuchi et al.,
1983
; Loffler et al., 1985
; Abubakar et al.,
1990
) and agreed with the order of inhibition of desensitization (table
1), suggesting that this action was responsible for the inhibition of
desensitization. However, this view was negated because two selective
inhibitors of phospholipase A2, manoalide and
p-bromophenacyl bromide, had no significant effect on
desensitization (fig. 2). Manoalide at the concentration tested was
fully effective as a phospholipase A2 inhibitor,
to the same extent as quinacrine (Nishimura et al., 1995
).
Previously, Siegel et al. (1984)
showed a slight inhibition of desensitization by p-bromophenacyl bromide in guinea pig
ileum. However, higher concentration (5 × 10
6 M) of this drug than that used by them
(10
7 M) had no inhibitory effect. These
results indicated that local anesthetics did not inhibit
desensitization through their inhibitory action on phospholipase
A2.
Muscarinic stimulation inhibits voltage-gated
Ca++ channel currents in smooth muscle cells
(Mitsui and Karaki, 1990
; Russell and Aaronson, 1990
; Unno et
al., 1995
), suggesting that an inactivation of voltage-gated
Ca++ channels is responsible for desensitization
(Himpens et al., 1991
). Because most local anesthetics
interact with Ca++ channels (Spedding and Berg,
1985
), their inhibitory effects during desensitization might protect
Ca++ channels from being desensitized. Our test,
however, showed that the potency order of these local anesthetics in
inhibiting Ca++ channels did not agree with that
of inhibiting desensitization. Especially, chloroquine had a 10-fold
stronger effect than tetracaine on desensitization (table 1), whereas
both drugs had the same effect on Ca++ channels
(table 2). Moreover, quinacrine and chloroquine, both potent inhibitors
of desensitization, did not inhibit Ca++ channel
currents at the concentration of IC50 for
desensitization (fig. 3). These results indicated that local
anesthetics did not inhibit desensitization through their action on
Ca++ channels. This conclusion is in accord with
that of Hishinuma and Uchida (1987)
showing that dibucaine, with
stronger inhibitory effect than tetracaine on
Ca++ channels, did not inhibit agonist-induced
desensitization of guinea pig taenia.
The present study clearly demonstrated that quinacrine, chloroquine,
tetracaine and procaine interacted with muscarinic receptors in guinea
pig ileal longitudinal muscle. However, there were some differences in
the manner each drug interacted with the receptor. That is, tetracaine
and procaine were competitive at this receptor, as shown by the good
agreement of the pKi values of each drug with the corresponding pKB values and by
the results from the combined dose-ratio test of Paton and Rang (1965)
.
On the other hand, chloroquine was only partially competitive, and
quinacrine was noncompetitive at muscarinic receptors according to the
results of the combined dose-ratio test. The disagreement of the
pKi values of these drugs with the
corresponding pKB values also supported this view. Our result on the competitive interaction of tetracaine and
procaine with muscarinic receptors was in accord with that of previous
studies (Richelson et al., 1978
; Fairhurst et
al., 1980
; Taylor et al., 1980
; Aguilar et
al., 1980
; Hisayama et al., 1989
), although some of
these studies indicated that the interaction became noncompetitive (or
allosteric) at higher drug concentrations. On the other hand, the
present study showed that quinacrine bound to this receptor in a
noncompetitive manner, indicating that it bound to a site different
from the receptor site (i.e., an allosteric site)
and led to the inhibition of the binding of agonist and antagonist to
the receptor site.
Each local anesthetic, whether its action on muscarinic receptors is
competitive or not, would inhibit agonist binding to the receptor site.
Therefore, it is probable that these drugs inhibited desensitization
through their blocking action on the receptor. The result that the
order of potency of these drugs in inhibiting desensitization agreed
well with the rank order of affinity for the receptors (table 1)
supported this view. To check this point, we examined the effects of
these drugs on receptor occupancy by agonist. Quinacrine, chloroquine
and tetracaine reduced receptor occupancy only slightly, that is, from
99.0% (control) to 96.8%, 95.1% and 89.4%, respectively, under
conditions when the desensitizing treatment (coexistence of agonist and
the inhibitor) induced half-maximum inhibition of desensitization, whereas procaine reduced it to 49.8%. These results indicated that
quinacrine, chloroquine and tetracaine exerted only slight blocking
action on the receptor, which was insufficient for inhibiting desensitization, whereas procaine could have inhibited desensitization through its antagonizing action.
Nevertheless, there remained the possibility that these local
anesthetics inhibited desensitization through their action on the
receptor. It should be noted that the Ki
values of quinacrine and chloroquine were smaller than the
corresponding KB values by factors of 10 to 20, indicating that these drugs interacted with the receptor under
such conditions that they did not inhibit agonist-binding (more
correctly, agonist-induced contraction, because the
pKB values were obtained from functional
studies). These drugs probably acted on the allosteric site, altered
the conformation of the receptor site and thus modified ligand receptor interaction. Therefore, it was possible that muscarinic agonist stimulated two cellular processes in parallel; the contractile process
and desensitization process, and that the local anesthetics inhibited
desensitization process specifically at the concentrations whereby
contractile process was not inhibited. This idea is supported by the
findings that muscarinic stimulation is mediated by two types of G
protein: pertussis toxin-sensitive G protein and pertussis toxin-insensitive G protein (Inoue and Isenberg, 1990
; Unno et al., 1995
); the former leads to opening of nonselective cationic channels and contraction of smooth muscle, and the latter leads to
inactivation of voltage-gated Ca++ channel
currents and possibly to desensitization. Tetracaine could have
inhibited desensitization by a similar mechanism because this drug
acted allosterically at higher concentrations (Taylor et
al., 1980
; Aguilar et al., 1980
).
In conclusion, our results showed that although local anesthetics
interacted with muscarinic receptors, they did not inhibit desensitization through their simple blocking action on the receptors (except for procaine). However, there remained the possibility that
these local anesthetics bound to an allosteric site on the receptor,
modified agonist receptor interaction (e.g., the
coupling between the receptor and a G protein) and thus inhibited the
pathway specific to the desensitization process. To elucidate this
point further requires additional work.
Accepted for publication March 13, 1998.
Received for publication September 5, 1997.